Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Amin

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
JMIR Formative Research|June 10, 2025
Caregivers' Perceptions of Clinical Symptoms, Disease Management, and Quality of Life Impact in Cases of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Cross-Sectional Online SurveySam Amin, Carol-Anne Partridge, Helen Leonard, et al.
The Patient|July 11, 2026
Co-Creation of the EpiCom Clinical Trial: Bringing the Tuberous Sclerosis Complex Patient Community, Healthcare Professionals, and the Pharmaceutical Industry TogetherLisa Moore-Ramdin, Agnies van Eeghen, Joanne Stevens, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 28, 2012
The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complexSam Amin, Michael Carter, Richard J Edwards, et al.
Plos One|June 12, 2025
Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)Agnies M van Eeghen, Elizabeth A Thiele, Sam Amin, et al.
Archives of Disease in Childhood|May 9, 2024
Consensus recommendations for the assessment and management of idiopathic intracranial hypertension in children and young peopleSam Amin, Marie Monaghan, Katharine Forrest, et al.
Genetic Testing and Molecular Biomarkers|January 22, 2025
REVEAL-CP: Selective Screening of Pediatric Patients for Aromatic L-Amino Acid Decarboxylase Deficiency with a Guthrie Card and <i>In Silico</i> Structural Modeling of One Index CaseEugen-Matthias Strehle, Roberta Battini, Vasantha Gowda, et al.
Archives of Disease in Childhood|April 6, 2019
Pharmacological management of abnormal tone and movement in cerebral palsyDaniel E Lumsden, Belinda Crowe, Anna Basu, et al.
Archives of Disease in Childhood|October 15, 2025
Deep brain stimulation in the management of movement disorders in childhood: a UK-wide cross-sectional studyDaniel E Lumsden, Ramalakshmi Ramiah, Todd Smallbone, et al.
Epilepsia Open|March 7, 2024
Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journeySam Amin, Rikke S Møller, Angel Aledo-Serrano, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
JMIR Formative Research|June 10, 2025
Caregivers' Perceptions of Clinical Symptoms, Disease Management, and Quality of Life Impact in Cases of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Cross-Sectional Online SurveySam Amin, Carol-Anne Partridge, Helen Leonard, et al.
The Patient|July 11, 2026
Co-Creation of the EpiCom Clinical Trial: Bringing the Tuberous Sclerosis Complex Patient Community, Healthcare Professionals, and the Pharmaceutical Industry TogetherLisa Moore-Ramdin, Agnies van Eeghen, Joanne Stevens, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 28, 2012
The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complexSam Amin, Michael Carter, Richard J Edwards, et al.
Plos One|June 12, 2025
Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)Agnies M van Eeghen, Elizabeth A Thiele, Sam Amin, et al.
Archives of Disease in Childhood|May 9, 2024
Consensus recommendations for the assessment and management of idiopathic intracranial hypertension in children and young peopleSam Amin, Marie Monaghan, Katharine Forrest, et al.
Genetic Testing and Molecular Biomarkers|January 22, 2025
REVEAL-CP: Selective Screening of Pediatric Patients for Aromatic L-Amino Acid Decarboxylase Deficiency with a Guthrie Card and <i>In Silico</i> Structural Modeling of One Index CaseEugen-Matthias Strehle, Roberta Battini, Vasantha Gowda, et al.
Archives of Disease in Childhood|April 6, 2019
Pharmacological management of abnormal tone and movement in cerebral palsyDaniel E Lumsden, Belinda Crowe, Anna Basu, et al.
Archives of Disease in Childhood|October 15, 2025
Deep brain stimulation in the management of movement disorders in childhood: a UK-wide cross-sectional studyDaniel E Lumsden, Ramalakshmi Ramiah, Todd Smallbone, et al.
Epilepsia Open|March 7, 2024
Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journeySam Amin, Rikke S Møller, Angel Aledo-Serrano, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
Pageof 3